Related Experiment Video
Updated: May 28, 2026
High Content Screening in Neurodegenerative Diseases
Published on: January 6, 2012
A human TREK-1/HEK cell line: a highly efficient screening tool for drug development in neurological diseases
Hamid Moha ou Maati1, Rémi Peyronnet, Christelle Devader
1Institut de Pharmacologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique (UMR6097), Université de Nice Sophia Antipolis, Valbonne, France.
Abstract:
TREK-1 potassium channels are involved in a number of physiopathological processes such as neuroprotection, pain and depression. Molecules able to open or to block these channels can be clinically important. Having a cell model for screening such molecules is of particular interest. Here, we describe the development of the first available cell line that constituvely expresses the TREK-1 channel. The TREK-1 channel expressed by the h-TREK-1/HEK cell line has conserved all its modulation properties. It is opened by stretch, pH, polyunsaturated fatty acids and by the neuroprotective molecule, riluzole and it is blocked by spadin or fluoxetine. We also demonstrate that the h-TREK-1/HEK cell line is protected against ischemia by using the oxygen-glucose deprivation model.
Insights
Researchers developed a novel cell line expressing the TREK-1 potassium channel. This TREK-1 channel cell model retains its functional properties and shows promise for drug screening and understanding neuroprotection.
Area of Science:
- Molecular Biology
- Neuroscience
- Pharmacology
Background:
- TREK-1 potassium channels play crucial roles in neuroprotection, pain, and depression.
- Modulators of TREK-1 channels hold significant therapeutic potential.
- A reliable cell model is essential for screening TREK-1 channel modulators.
Purpose of the Study:
- To develop the first constitutively TREK-1 expressing cell line.
- To validate the functional properties and modulation of the expressed TREK-1 channel.
- To assess the utility of the cell line in a neuroprotection model.
Main Methods:
- Development of a HEK cell line stably expressing the human TREK-1 channel (h-TREK-1/HEK).
- Characterization of TREK-1 channel modulation by various stimuli (stretch, pH, fatty acids, drugs).
- Evaluation of cellular protection against oxygen-glucose deprivation (ischemia model).
Main Results:
- The h-TREK-1/HEK cell line constitutively expresses functional TREK-1 channels.
- The channel activity was modulated as expected by known activators (stretch, pH, polyunsaturated fatty acids, riluzole) and inhibitors (spadin, fluoxetine).
- The h-TREK-1/HEK cell line demonstrated protection against oxygen-glucose deprivation-induced injury.
Conclusions:
- The novel h-TREK-1/HEK cell line is a valuable tool for studying TREK-1 channel function.
- This cell line is suitable for high-throughput screening of potential TREK-1 modulators.
- The model confirms TREK-1 channel's role in cellular protection against ischemic conditions.
More Related Videos
17:28Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
09:19High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
Published on: January 4, 2015